TRAVERE THERAPEUTICS, INC.

Company

Travere Therapeutics, Inc.

Filed

October 28, 2022

Accession Number

0000902664-22-004681

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →